Skip to content
Lower risk Drug recall · FDA · Published October 23, 2024

Cipla USA Lanthanum Carbonate Tablets Recall: Crushed Tablets Reported

Cipla USA recalls 1000mg Lanthanum Carbonate Chewable Tablets due to complaints of crushed and broken tablets. No remedy specified in official notice.

🇺🇸 FDA recall #D-0043-2025DrugCipla USA ›
Take action

Contact the company

Recalling firmCipla USA, Inc.10 Independence Blvd · Warren, NJ 07059-2730
✎ GovInfoNow plain-language explainer

Cipla USA is recalling 1000mg Lanthanum Carbonate Chewable Tablets (10-count bottles) because customers reported tablets breaking or crumbling. This could lead to inconsistent dosing if the medication doesn't dissolve properly. Read more at govinfonow.com/recall/32499-cipla-usa-lanthanum-carbonate-tablets-recall-crushed-tablets-reported.

Source Summary by GovInfoNow · govinfonow.com/recall/32499-cipla-usa-lanthanum-carbonate-tablets-recall-crushed-tablets-reported · Updated September 23, 2026 · FDA enforcement record: FDA #D-0043-2025

Cite this page

“Cipla USA Lanthanum Carbonate Tablets Recall: Crushed Tablets Reported.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32499-cipla-usa-lanthanum-carbonate-tablets-recall-crushed-tablets-reported. Based on FDA recall #D-0043-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0043-2025%22&limit=1).

The FDA announced on Oct. 23, 2024, that Cipla USA is recalling Lanthanum Carbonate Chewable Tablets due to failed specifications involving crushed and broken tablets. This voluntary Class II recall affects 1,875 boxes distributed nationwide.

How to tell if you have it

  • Brand: Cipla USA
  • Product: Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only
  • NDC: 69097-0936-98
  • Lot #: NB240316
  • Expiration Date: 12/31/25

The hazard

The recall addresses complaints of crushed and broken tablets, which constitute a failure to meet tablet specifications. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Cipla USA has 12 other recalls on record since June 27, 2023. Recent brand recalls include the June 29, 2026, Cipla Cinacalcet Tablets recall for N-nitroso-cinacalcet over daily intake and the March 13, 2026, Lanreotide Injection recall for sterility issues. Other recent recalls of similar products include the Oct. 31, 2025, Cipla Phytonadione Injectable Emulsion recall for stability issues and the May 27, 2026, Lannett Niacin Extended-release Tablets recall for failed dissolution testing.

How to tell if you have this one

Check for the 10-count bottle labeled 'Lanthanum Carbonate Chewable Tablets, 1000mg' with NDC 69097-0936-98 and lot number NB240316. The expiration date is December 31, 2025.

  • Brand
    Cipla USA
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    USA nationwide.
Recall numberProduct, codes & lotsQuantity
D-0043-2025Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98; Lot # NB240316, Exp 12/31/251,875 boxes (cipla and exlan)
D-0044-2025Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90; Lot# NB240873, Exp 03/31/2026N/A
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label includes the NDC 69097-0936-98 and lot number NB240316 for the recalled item.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: Oct 23, 202412. FDA classified it Class II: Nov 12, 202423. Published in FDA’s Enforcement Report: Nov 20, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Cipla USA recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0043-2025 (October 23, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0043-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA